Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Dominic Pilon

8PUBLICATIONS
14CO-AUTHORS
Psychological methodology, design and analysisPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Jun 12, 2026
Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis.

|Feb 25, 2026
Prescriber- and Patient-Level Characteristics Associated with Patient Adherence to Any Antipsychotics Among Patients with Schizophrenia in the United States.

Arthur Voegel, Ronaldo R Naranjo, Lilian Diaz

|Jul 31, 2024
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer.

Mehmet A Bilen, Ibrahim Khilfeh, Carmine Rossi

|Sep 06, 2023
Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States.

Maryia Zhdanava, Ruizhi Zhao, Ameur M Manceur

|May 02, 2023
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States.

Maryia Zhdanava, Amanda Teeple, Dominic Pilon

|Mar 16, 2023
Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial health plans.

Kruti Joshi, Dominic Pilon, Aditi Shah

Pageof 2

Frequent Collaborators

3 joint publications

Maryia Zhdanava

2 joint publications

Leslie Citrome

1 joint publications

Zhijie Ding

1 joint publications

Ameur M Manceur

1 joint publications

Carmine Rossi

1 joint publications

Anaïs Lemyre

1 joint publications

Qiaoyi Zhang

1 joint publications

Carol Mao

1 joint publications

Todor I Totev

1 joint publications

Marjolaine Gauthier-Loiselle

Frequent Collaborators

3 joint publications

Maryia Zhdanava

2 joint publications

Leslie Citrome

1 joint publications

Zhijie Ding

1 joint publications

Ameur M Manceur